Ronald de Wit Selected Research

Docetaxel (Taxotere)

1/2022	Real-world evidence of patients with metastatic castration-resistant prostate cancer treated with cabazitaxel: comparison with the randomized clinical study CARD.
10/2021	Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.
10/2021	Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study.
8/2021	Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
12/2020	Androgen receptor signalling impairs docetaxel efficacy in castration-resistant prostate cancer.
11/2020	Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE).
11/2020	Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study.
1/2020	Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
12/2019	Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.
10/2019	Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald de Wit Research Topics

Disease

80	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 10/2004
44	Neoplasms (Cancer) 01/2022 - 04/2003
19	Pain (Aches) 01/2022 - 10/2004
15	Carcinoma (Carcinomatosis) 01/2022 - 08/2005
8	Disease Progression 11/2020 - 11/2007
7	Testicular Neoplasms (Testicular Cancer) 02/2021 - 03/2003
7	Circulating Neoplastic Cells 01/2021 - 12/2015
6	Neutropenia 01/2022 - 01/2013
6	Neoplasm Metastasis (Metastasis) 10/2021 - 11/2007
6	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2021 - 10/2007
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 02/2003
5	Fatigue 11/2017 - 09/2012
5	Vomiting 03/2015 - 11/2003
5	Nausea 03/2015 - 11/2003
4	Seminoma 10/2021 - 12/2006
3	Diarrhea 10/2021 - 09/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2010 - 10/2007
2	Asthenia 10/2021 - 04/2015
2	Non-Muscle Invasive Bladder Neoplasms 01/2021 - 01/2021
2	Febrile Neutropenia 01/2020 - 04/2015
2	Urologic Neoplasms (Urological Cancer) 03/2018 - 01/2017
2	Pulmonary Embolism 04/2015 - 03/2015
2	Seizures (Absence Seizure) 01/2015 - 09/2012
2	Hodgkin Disease (Hodgkin's Disease) 01/2010 - 12/2009
1	Spinal Cord Compression 01/2022
1	Spontaneous Fractures (Pathological Fracture) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Aneuploidy (Aneuploid) 01/2022
1	Carcinogenesis 02/2021
1	Colorectal Neoplasms (Colorectal Cancer) 02/2021
1	Carcinoma in Situ 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Nonseminomatous germ cell tumor 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020

Drug/Important Bio-Agent (IBA)

40	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2004
24	cabazitaxel FDA Link 01/2022 - 03/2015
18	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 03/2003
16	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 09/2012
16	Prednisone (Sone)FDA LinkGeneric 01/2021 - 10/2004
15	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 10/2004
14	enzalutamideIBA 01/2022 - 09/2012
14	AndrogensIBA 11/2021 - 03/2005
13	pembrolizumabIBA 01/2022 - 01/2017
13	PlatinumIBA 01/2022 - 07/2016
12	abirateroneIBA 01/2022 - 03/2015
11	Pharmaceutical PreparationsIBA 01/2021 - 09/2005
9	Hormones (Hormone)IBA 01/2019 - 10/2004
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2008
6	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2014 - 10/2004
5	RamucirumabIBA 01/2022 - 11/2017
5	taxaneIBA 01/2021 - 06/2014
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
4	Etoposide (VP 16)FDA LinkGeneric 10/2021 - 03/2003
4	Abiraterone AcetateIBA 01/2021 - 03/2015
4	Carboplatin (JM8)FDA LinkGeneric 01/2018 - 12/2006
4	Taxoids (Taxanes)IBA 01/2018 - 06/2014
4	Alkaline PhosphataseIBA 11/2017 - 11/2007
4	Gemcitabine FDA Link 04/2012 - 02/2003
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2018
3	B7-H1 AntigenIBA 01/2022 - 10/2020
3	apalutamideIBA 10/2021 - 01/2018
3	Vinblastine (Vinblastine Sulfate)FDA Link 01/2012 - 04/2003
3	Methotrexate (Mexate)FDA LinkGeneric 01/2012 - 04/2003
3	Aprepitant (Emend)FDA Link 02/2007 - 11/2003
3	AntiemeticsIBA 02/2007 - 08/2005
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Testosterone (Sustanon)FDA Link 12/2020 - 01/2018
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2020 - 04/2003
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020 - 11/2017
2	Messenger RNA (mRNA)IBA 08/2019 - 01/2018
2	LigandsIBA 01/2017 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 03/2012
2	orteronelIBA 03/2015 - 03/2015
2	Amylases FDA Link 03/2015 - 03/2015
2	danusertibIBA 01/2013 - 03/2012
2	Bleomycin (Blenoxane)FDA LinkGeneric 03/2012 - 03/2003
2	Dexamethasone (Maxidex)FDA LinkGeneric 06/2011 - 02/2007
2	Hemoglobins (Hemoglobin)IBA 01/2010 - 11/2007
1	Monoclonal AntibodiesIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Prednisolone (Predate)FDA LinkGeneric 10/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2021
1	Biological ProductsIBA 03/2021
1	Calcibiotic Root Canal SealerIBA 02/2021
1	mesoglycanIBA 01/2021
1	11-ketotestosteroneIBA 01/2021
1	gallium 68 PSMA-11IBA 11/2020
1	Immunoglobulin G (IgG)IBA 01/2020

Therapy/Procedure

62	Castration 06/2022 - 09/2009
51	Drug Therapy (Chemotherapy) 01/2022 - 02/2003
31	Therapeutics 01/2022 - 02/2003
7	Radiotherapy 01/2022 - 08/2005
4	Cystectomy 01/2021 - 01/2015
2	Aftercare (After-Treatment) 01/2018 - 01/2010
1	Orthopedic Procedures 01/2022
1	Immunotherapy 01/2021
1	Transurethral Resection of Bladder 01/2021
1	Neoadjuvant Therapy 01/2021
1	Drug Tapering 01/2020